Search Contract Opportunities

Alendronate Sodium Tablets   3

ID: SPE2D2-25-R-0023 • Type: Solicitation • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:

Description

Posted: Oct. 23, 2025, 2:05 p.m. EDT

Amendment 0001 has been issued to extend the solicitation closing date to November 3, 2025.

All other terms and conditions of the solicitation remain unchanged.

Posted: Sept. 25, 2025, 1:53 p.m. EDT
Background
The solicitation SPE2D2-25-R-0023 is issued by the Defense Logistics Agency (DLA) Troop Support, which is responsible for providing logistics support to the Department of Defense (DoD) and other federal agencies. The goal of this contract is to procure Alendronate Sodium Tablets, which are essential for treating osteoporosis and other bone-related conditions. This procurement aims to ensure a steady supply of these pharmaceuticals to meet the needs of military and health service personnel.

Work Details
The contract involves the delivery of Alendronate Sodium Tablets in two dosages: 35MG and 70MG, each packaged as 4 blister tablets per box. The estimated quantities required are as follows:

- Item No. 0001: Alendronate Sodium 35MG tablet – 4 Count
- Base Year: 52,228 BX
- Option Year 1: 52,228 BX
- Option Year 2: 52,228 BX
- Option Year 3: 52,228 BX
- Option Year 4: 52,228 BX

- Item No. 0002: Alendronate Sodium 70MG tablet – 4 Count
- Base Year: 393,517 BX
- Option Year 1: 393,517 BX
- Option Year 2: 393,517 BX
- Option Year 3: 393,517 BX
- Option Year 4: 393,517 BX

Note that these quantities are estimates only and are specifically for the Department of Defense (DoD) and Indian Health Service (IHS) demands.

Period of Performance
The contract will have a base year followed by four option years.

Place of Performance
The products will be delivered to various locations as specified by the Department of Defense and Indian Health Service.

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
Nov. 3, 2025, 3:00 p.m. EST (original: Oct. 27, 2025, 3:00 p.m. EDT) Past Due
Posted
Sept. 25, 2025, 1:53 p.m. EDT (updated: Oct. 23, 2025, 2:05 p.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 9/25/25 DLA Troop Support - Medical issued Solicitation SPE2D2-25-R-0023 for Alendronate Sodium Tablets due 11/3/25. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Courtney Hunter   Profile
Email
courtney.hunter@dla.mil
Phone
None

Secondary Contact

Name
Jason Wray   Profile
Email
jason.wray@dla.mil
Phone
(445) 737-6304

Documents

Posted documents for Solicitation SPE2D2-25-R-0023

Opportunity Assistant

AI Analysis
AI Generate

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D2-25-R-0023

Award Notifications

Agency published notification of awards for Solicitation SPE2D2-25-R-0023

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D2-25-R-0023

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D2-25-R-0023

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D2-25-R-0023

Experts for Alendronate Sodium Tablets

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Oct. 23, 2025
Last Updated By
courtney.hunter-stangler@dla.mil
Archive Date
Sept. 25, 2031